Ann Allergy Asthma Immunol. 2022 Aug;129(2):169-180. doi: 10.1016/j.anai.2022.02.021. Epub 2022 Mar 7.
PMID:35272048
Filarial tropical pulmonary eosinophilia.
Joob B, Wiwanitkit V.
J Asthma. 2020 Feb;57(2):230. doi: 10.1080/02770903.2018.1561892. Epub 2019 Feb 5.
PMID:30720371
Severe eosinophilic asthma in Chinese C-BIOPRED asthma cohort.
Zhang Q, Fu X, Wang C, Shen H, Zhu L, Shi G, Qiu Z, Wen Z, Gu W, Luo W, Zhao L, Chen Y, Lim S, Xiao C, Kang J, Zhang Y, Huang M, Xu J, Huang K, Li Q, Zhang X, Zhao J, Liu X, Sun S, Tang H, He B, Cai S, Chen P, Wei C, Wang G, Chen P, Xie L, Lin J, Tang Y, Han Z, Chung KF, Zhong N; C-BIOPRED consortium.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators.
Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7.